Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention TrialAlan R. Kristal, Ian M. Thompson, Jeannette M. Schenk et al.|American Journal of Epidemiology|2008Cited by 82
Insulin‐like growth factor‐I, insulin‐like growth factor binding protein‐3 and risk of benign prostate hyperplasia in the prostate cancer prevention trialMarian L. Neuhouser, Alan R. Kristal, Ian M. Thompson et al.|The Prostate|2008Cited by 56
Serum Retinol and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialJeannette M. Schenk, Ulrike Peters, Douglas J. Reding et al.|Cancer Epidemiology Biomarkers & Prevention|2009Cited by 33